Skip to contentM
Microbot Medical Inc.
M
MBOTMicrobot Medical Inc. Q2 2019 · 10-Q
Revenue—
Net Income-$1.54M-$1.54MN/M vs Q2 2018 EPS Diluted-$0.36-$0.36N/M vs Q2 2018 Operating Income-$1,545,000N/M Operating Cash Flowderived-$477,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Microbot Medical Inc. · CIK 883975 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end